Similar articles

• [Antithrombin III and alpha-2-antiplasmin activities compared with other hemostasis parameters in uncomplicated diabetes mellitus, type 2].

  Kotschy M, Drewniak W, Graczykowska-Koczorowska A, Listopadzki D. Kotschy M, et al. Pol Tyg Lek. 1992 Jan 6-13;47(1-2):17-8. Pol Tyg Lek. 1992. PMID: 1409034 Polish.
• PARD: platelet aggregation as a risk factor in diabetics: results of a prospective study.

  Breddin HK, Krzywanek HJ, Althoff P, Schöffling K, Uberla K. Breddin HK, et al. Horm Metab Res Suppl. 1985;15:63-8. Horm Metab Res Suppl. 1985. PMID: 2934312
• [Thrombosis and diabetic angiopathy].

  Dupuy E, Guillausseau PJ, Lubetzki J. Dupuy E, et al. Nouv Rev Fr Hematol (1978). 1982;24(3):173-7. Nouv Rev Fr Hematol (1978). 1982. PMID: 6215622 French. No abstract available.
• Diabetes mellitus, vascular disease and thrombosis.

  Banga JD, Sixma JJ. Banga JD, et al. Clin Haematol. 1986 May;15(2):465-92. Clin Haematol. 1986. PMID: 3524933 Review. No abstract available.
• [Diabetes, coagulation and vascular events].

  Nenci GG, Paliani U. Nenci GG, et al. Recenti Prog Med. 2000 Feb;91(2):86-90. Recenti Prog Med. 2000. PMID: 10748654 Review. Italian.